Intravenous Pilot Trial A randomised, double-blind pilot trial involved 21 participants with Parkinsons disease
Weve known that GLP-1 drugs suppress feeding behavior driven by energy demand, said co-corresponding author Ali Guler, PhD, a professor of biology at the University of Virginia
By lowering LDL cholesterolpossibly through direct glucagon effects on the liver and LDL receptorsit holds promise not only for weight management but also for reducing cardiovascular disease risk at its root
This deck provides essential guidelines, research findings, and practical applications, empowering healthcare professionals to effectively implement GLP-1 treatments for enhanced patient outcomes and long-term weight management success
It is crucial to understand that in the UK, tirzepatide is only available as pre-filled, single-dose pens (Mounjaro for diabetes, Zepbound for weight management) ready for subcutaneous injection
Lost in this conversation are the patients who have come to rely on the compounded versions of tirzepatide and semaglutide